Learn more

IL DONG PHARMA

Overview
  • Total Patents
    133
  • GoodIP Patent Rank
    27,535
  • Filing trend
    ⇩ 15.0%
About

IL DONG PHARMA has a total of 133 patent applications. It decreased the IP activity by 15.0%. Its first patent ever was published in 1978. It filed its patents most often in Republic of Korea, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and foods and drinks are BEIJING KAWIN TECHNOLOGY SHARE HOLDING CO LTD, CELLCENTRIC LTD and OR YAT SUN.

Patent filings per year

Chart showing IL DONG PHARMAs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Kang Jae Hoon 38
#2 Kang Jae-Hoon 28
#3 Lee Hong-Sub 16
#4 Seo Myeong Won 13
#5 Kim Tae Yong 11
#6 Kwon Jae Wook 10
#7 Kwon Sung-Wook 10
#8 Kwon Hyuk Sang 10
#9 Jeong Jin-Ah 10
#10 Kim Jeong-Guen 9

Latest patents

Publication Filing date Title
KR20210027305A Multicoating pharmaceutical composition containing duloxetin
KR20210015077A A novel benzofuran derivatives and uses thereof
WO2020262755A1 Novel probiotic composition for regulation of intestinal immunity
KR20200120177A Novel Salt of 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine, method of preparing the same and pharmaceutical composition comprising the same
KR20200114870A System and method for providing integrated medical institution information and insurance benefit information
KR20200014049A Pharmaceutical composition having storage stability for the treatment of hypertension and hyperlipidermia
KR20180115233A An isoxazole derivatives as nuclear receptor agonist and used thereof
WO2018190643A1 An isoxazole derivatives as nuclear receptor agonists and used thereof
KR20180069718A Novel phenyl propionic acid derivatives and uses thereof
KR20190048739A Lactobacillus johnsonii IDCC9203 having effect of preventing and improving inflammation, and uses thereof
KR20190048732A Lactobacillus johnsonii IDCC9203 having effect of preventing and treating inflammation, and uses thereof
KR20170081607A Composition comprising the homoisoflavanone for preventing or treating of dementia
KR20180115126A A substituted bicyclic compound as bile acid receptors agonist and used thereof
KR20180113822A Novel polymorphous form of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine and process for the preparation thereof)
KR20180073085A Novel phenyl propionic acid compound as GPR40 agonist
KR101858733B1 Method for preparing super low molecular weight of hyaluronic acid
KR20180009195A Orotic acid salt of antiviral agent, a method for preparing the salt and pharmaceutical composition comprising the salt
KR20170139966A Pharmaceutical composition having improved hygroscopicity for the treatment of hypertension and impotence
KR20170134019A Novel 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-amino-piperidin-1-yl)-xanthine(Linagliptin) ferulic acid salt and process for the preparation thereof
KR20170098031A Novel morpholine diphosphate salt, and method for manufacturing high purity rivaroxaban using same